ArticleThe American journal of surgical pathology2014

SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.

Ta-Chiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.